Denmark
Øresund Pharma ApS is an emerging force in the Health Care and Pharmaceutical sectors, strategically positioning itself in the competitive landscape of Europe. Founded in 2018 and headquartered in Copenhagen, Denmark, the company has swiftly extended its market presence, with its products now reaching over 20 countries.
The company's unique approach blends the accessibility of generic medicines with innovative value-added solutions, underscored by a robust regulatory foundation and an entrepreneurial spirit. This combination is designed to foster scalable business growth while maintaining high standards of quality and accessibility.
Currently, Øresund Pharma boasts a dynamic team of over 25 colleagues, all championing an environment where speed, accountability, and collaboration are key. Although exact investment figures are undisclosed and no recent investors are mentioned, the company's trajectory suggests potential for attractive investment opportunities, especially for those interested in a burgeoning pharmaceutical enterprise.
